“agios-pharmaceuticals” Archives

in
Entry Author Date Location
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another 06/11/16 Boston
The Biotech Roundup: Immunotherapy Ups And Downs, Gene Deals & More 05/20/16 National
Agios, Celgene Jump into Immuno-Oncology in Revamped Alliance 05/17/16 Boston
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors 03/30/16 New York
Hear Lew Cantley, Others on Shaping NY Biotech on March 29 03/11/16 New York
With Second Eye Drug Flop, Eleven Heads Back to Drawing Board 01/19/16 Boston
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
At Hematological Meeting, More Than Just Biotech Data Runs Blood Red 12/08/15 National
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More 09/21/15 Boston
Versant Walks Biotech “High Line” With a New Manhattan Incubator 08/24/15 New York
Flagship CEO on Backing NY Biotech, Moderna, and Investing in a Boom 06/22/15 New York
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
Eleven Bio’s Shares Routed as Dry Eye Drug Flunks Phase 3 Test 05/18/15 Boston
Denali Rises With $217M and Genentech Alumni to Fight Brain Diseases 05/14/15 San Francisco
East Coast Biotech Roundup: Celgene, Blueprint(s), Intarcia & More 05/01/15 Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech 04/29/15 New York
Flagship Ventures Raises Sails for $537M Fund, Its Largest to Date 03/26/15 Boston
Epizyme Buys Back Control of Cancer Drug From Eisai For up to $110M 03/12/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
At ASH, Sunesis Dices Data to Argue For “Failed” Leukemia Drug 12/07/14 San Francisco
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Déjà Vu for Agios as Second Drug Shines in Small Blood Cancer Study 11/18/14 Boston
Page 1 of 4 next page »